Biospecifics Technologies (BSTC) Tops Q2 EPS by 2c

Biospecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.25 million.

For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49